ArticleInternal medicine (Tokyo, Japan)2025

Hepatocellular Carcinoma Presenting with Pseudoprogression in a Patient Receiving Atezolizumab Plus Bevacizumab Combination Therapy.

Takahiro Osuga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.